Teva launches type 2 diabetes generic

5/16/2017

JERUSALEM — Teva Pharmaceutical Industries launched generic Glumetza (metformin hydrochloride extended-release tablets), 500 mg and 1000 mg, in the United States.


Metformin hydrochloride extended-release tablets are used with diet and exercise to help control high blood sugar in adults with type 2 diabetes mellitus. Metformin hydrochloride extended-release tablets are not for people with type 1 diabetes or for people with diabetic ketoacidosis.


More than 28 million people in the U.S. are living with type 2 diabetes; a serious disease that can be managed through physical activity, diet and appropriate use of medications to lower blood sugar levels.


Glumetza is manufactured by Valeant Pharmaceuitcals. It had annual sales of approximately $1.03 billion in the U.S., according to IMS data as of March 2017.


X
This ad will auto-close in 10 seconds